UnknownPhase 2

Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural

South Korea110 participantsStarted 2018-01-01

Plain-language summary

Prospective, single institute based, open label, double arm, randomized controlled trial Hypothesis: Pain control after resection of hepatobiliary tumors in patients with PCEA is more effective than in patients with IV-PCA.

Who can participate

Age range20 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pancreatobiliary malignancies * Anticipating open surgery * Written concent Exclusion Criteria: * History of previous upper abdominal open surgery * Psychiatric problems * Cognitive impairment * Chronic pain Elimination Criteria * Rejected written concent * Failure to follow instructions of doctor * Stopped surgery due to peritoneal metastasis

What they're measuring

Comparison of analgesic efficacy after major surgery in pancreatobiliary cancers: Intravenous patient-controlled analgesia versus patient-controlled epidural analgesia

Timeframe: Day 2 postoperatively

Trial details

NCT IDNCT04352023

SponsorNational Cancer Center, Korea

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-04-30

View on ClinicalTrials.gov More Pancreatic Cancer trials